AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26473996 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic (HYP)
Number of subjects: 6
Study 26473996 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot (HOT; 38°C/21% RH, inspired fraction of oxygen = 20.9%)
Number of subjects: 6
Study 26473996 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (CON, HOT, HYP)
Number of subjects: 6
Study 24158248 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1,800 mg daily plus statin (EPA group, n = 40)
Number of subjects: 80
Study 24158248 — intervention group
Group type: COMPARATOR
Intervention: Statin alone (Control group, n = 40)
Number of subjects: 80
Study 22170794 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 111
Study 22170794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 22170794 — intervention group
Group type: EXPERIMENTAL
Intervention: NAFLD patients
Number of subjects: 111
Study 20395860 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 51
Study 20395860 — intervention group
Group type: COMPARATOR
Intervention: Human albumin
Number of subjects: 51
Study 18225427 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 0
Study 18225427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15898479 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprivation
Number of subjects: 6
Study 15898479 — intervention group
Group type: EXPERIMENTAL
Intervention: Satiation
Number of subjects: 6
Study 15898479 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 6
Study 11870101 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate post-partum insertion of IUDs
Number of subjects: 0
Study 11870101 — intervention group
Group type: COMPARATOR
Intervention: Lippes Loops and Progestasert devices
Number of subjects: 0
Study 11870101 — intervention group
Group type: COMPARATOR
Intervention: Insertion techniques (hand vs instruments)
Number of subjects: 0
Study 10220202 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic stiffness measurement using echo-tracking sonography
Number of subjects: 40
Study 10220202 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic stiffness measurement using echo-tracking sonography, adjusted for diabetes duration
Number of subjects: 40
Study 8570263 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride (10 mg oral dose)
Number of subjects: 8
Study 2212182 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive community programming for drug abuse prevention (school, parent, mass media, and community organization)
Number of subjects: 8
Study 2212182 — intervention group
Group type: COMPARATOR
Intervention: Control condition (mass media and community organization only)
Number of subjects: 8
Study 7009502 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole and Kanamycin systemically
Number of subjects: 72
Study 7009502 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole and Kanamycin orally
Number of subjects: 72
Study 30520977 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily chemoradiotherapy (66 Gy in 33 fractions)
Number of subjects: 509
Study 30520977 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily chemoradiotherapy (45 Gy in 30 fractions)
Number of subjects: 509
Study 30520977 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage I to II disease
Number of subjects: 509
Study 30520977 — intervention group
Group type: COMPARATOR
Intervention: Stage III disease
Number of subjects: 509
Study 28251321 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg/kg diluted in normal saline up to 2 cc total volume injected before surgery
Number of subjects: 80
Study 28251321 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg/kg diluted in normal saline up to 2 cc total volume injected after surgery
Number of subjects: 80
Study 28251321 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol infiltration before surgery
Number of subjects: 80
Study 28251321 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol infiltration after surgery
Number of subjects: 80
Study 28251321 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study 25733461 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with maltodextrin (MD19)
Number of subjects: 30
Study 25733461 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium caseinate (SC) with maltodextrin (MD19)
Number of subjects: 30
Study 25733461 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (MD19) alone
Number of subjects: 30
Study 23998710 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical pacing (Group A)
Number of subjects: 71
Study 23998710 — intervention group
Group type: EXPERIMENTAL
Intervention: Septal pacing (Group S)
Number of subjects: 71
Study 23241931 — intervention group
Group type: EXPERIMENTAL
Intervention: Meriva (2 tablets/day, 2 x 500 mg of Meriva/day, corresponding to 2 x 100 mg curcumin/day)
Number of subjects: 61
Study 23241931 — intervention group
Group type: COMPARATOR
Intervention: Best Standard Management (BSM) alone
Number of subjects: 61
Study 19402344 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical formulations containing ketoprofen
Number of subjects: 0
Study 17451800 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (ICS)
Number of subjects: 19
Study 17451800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 15129311 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed internal sphincterotomy
Number of subjects: 79
Study 15129311 — intervention group
Group type: EXPERIMENTAL
Intervention: Open internal sphincterotomy
Number of subjects: 79
Study 11699613 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily for 8 days
Number of subjects: 15
Study 11699613 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg once daily for 8 days
Number of subjects: 15
Study 11699613 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole
Number of subjects: 15
Study 11699613 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole
Number of subjects: 15
Study 9591497 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral HRT (2 mg of estradiol on days 1‐12, 2 mg of estradiol plus 1 mg of norethisterone acetate on days 13‐22, and 1 mg of estradiol on days 23‐28; n = 21)
Number of subjects: 52
Study 9591497 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal HRT (50 microg/d of estradiol on days 1‐28 followed by 250 microg/d of norethisterone acetate on days 14‐28; n = 21)
Number of subjects: 52
Study 9591497 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal HRT (50 microg/d of estradiol on days 1‐28 followed by 250 microg/d of norethisterone acetate on days 14‐28; n = 10 female smokers)
Number of subjects: 52
Study 7843948 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 6 mg
Number of subjects: 86
Study 7843948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 3348073 — intervention group
Group type: EXPERIMENTAL
Intervention: Dixyrazine 0.5 mg kg‐1
Number of subjects: 90
Study 3348073 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine-scopolamine 0.15 mg kg‐1 and 0.0065 mg kg‐1
Number of subjects: 90
Study 3348073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 29277968 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (0.9 mg/day)
Number of subjects: 0
Study 29277968 — intervention group
Group type: COMPARATOR
Intervention: Insulin monotherapy (placebo)
Number of subjects: 0
Study 27374748 — intervention group
Group type: EXPERIMENTAL
Intervention: Alisporivir (Debio 025) in combination with pegylated interferon‐α2a
Number of subjects: 90
Study 27374748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 26359998 — intervention group
Group type: EXPERIMENTAL
Intervention: High-potency topical corticosteroid (betamethasone dipropionate)
Number of subjects: 16
Study 26359998 — intervention group
Group type: COMPARATOR
Intervention: Placebo saline solution
Number of subjects: 16
Study 23484344 — intervention group
Group type: EXPERIMENTAL
Intervention: High group entitativity condition
Number of subjects: 215
Study 23484344 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium group entitativity condition
Number of subjects: 215
Study 23484344 — intervention group
Group type: COMPARATOR
Intervention: Low group entitativity condition
Number of subjects: 215
Study 20569291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide-oxygen mixture (NOOM) inhalation
Number of subjects: 41
Study 20569291 — intervention group
Group type: COMPARATOR
Intervention: Lidocaïne-prilocaïne cream (LPC) application
Number of subjects: 41
Study 19105582 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestive materials leading to false beliefs about a negative experience with Pluto.
Number of subjects: 0
Study 19105582 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestive materials leading to a positive experience with Pluto.
Number of subjects: 0
Study 19105582 — intervention group
Group type: EXPERIMENTAL
Intervention: False beliefs induced by negative suggestions.
Number of subjects: 0
Study 16958738 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical subgingival application of doxycycline hyclate (DH) gel adjunctive to non-surgical periodontal therapy
Number of subjects: 18
Study 16958738 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 18
Study 12648557 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate-containing gum
Number of subjects: 20
Study 12648557 — intervention group
Group type: COMPARATOR
Intervention: Standard sugar-free gum
Number of subjects: 20
Study 10611130 — intervention group
Group type: EXPERIMENTAL
Intervention: Occluded glasses (left lens occluded)
Number of subjects: 143
Study 10611130 — intervention group
Group type: COMPARATOR
Intervention: Unoccluded glasses (no occlusion)
Number of subjects: 143
Study 9537145 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual keratometry (MK)
Number of subjects: 52
Study 9537145 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated keratometry (AK)
Number of subjects: 52
Study 9537145 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MK and AK
Number of subjects: 52
Study 1549964 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 50
Study 1549964 — intervention group
Group type: COMPARATOR
Intervention: Transthoracic echocardiography (TTE)
Number of subjects: 50
Study 2435071 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiologically guided antiarrhythmic drug therapy (group I)
Number of subjects: 166
Study 2435071 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (daily dose up to 200 mg) without invasive testing (group II)
Number of subjects: 166
Study 2435071 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (group III)
Number of subjects: 166
Study 30591031 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian capsules taken 60 minutes before bedtime for one month
Number of subjects: 39
Study 30591031 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules taken 60 minutes before bedtime for one month
Number of subjects: 39
Study 30591031 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian capsules
Number of subjects: 39
Study 30591031 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 39
Study 27747224 — intervention group
Group type: EXPERIMENTAL
Intervention: Ling Zhi preparation (3,000 mg)
Number of subjects: 12
Study 27747224 — intervention group
Group type: COMPARATOR
Intervention: Ling Zhi preparation (3,000 mg) with ascorbic acid (2,500 mg)
Number of subjects: 12
Study 25381393 — intervention group
Group type: EXPERIMENTAL
Intervention: DPYD*2A variant
Number of subjects: 2886
Study 25381393 — intervention group
Group type: EXPERIMENTAL
Intervention: D949V variant
Number of subjects: 2886
Study 25381393 — intervention group
Group type: EXPERIMENTAL
Intervention: I560S variant
Number of subjects: 2886
Study 22659339 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate monomer containing resin (Panavia 21 TC; N=16)
Number of subjects: 30
Study 22659339 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive bonding system with a phosphoric acid acrylate primer (Multilink‐Automix with Metal/Zirconia primer; N=14)
Number of subjects: 30
Study 20115947 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (IFX)
Number of subjects: 0
Study 20115947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18617735 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute quantification of N-acetylaspartate concentration in the hippocampus
Number of subjects: 69
Study 18617735 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute quantification of N-acetylaspartate concentration in the anterior periventricular and deep white matter
Number of subjects: 69
Study 18617735 — intervention group
Group type: COMPARATOR
Intervention: Relative ratio using creatine as a reference
Number of subjects: 69
Study 16011291 — intervention group
Group type: EXPERIMENTAL
Intervention: Acanthopanax senticosus injection (ASI) for 21 days
Number of subjects: 73
Study 11836281 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg TU im at wk 2, 6, 12, and 18 combined with 200 mg NETE im at wk 0, 6, 12, and 18 (group I)
Number of subjects: 26
Study 11836281 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg TU im at wk 2, 6, 12, and 18 combined with 400 mg NETE im at wk 0, 6, 12, and 18 (group II)
Number of subjects: 26
Study 11836281 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg TU im at wk 2, 6, 12, and 18 with daily oral NET acetate (NETA) from wk 0 to 24 (group III)
Number of subjects: 26
Study 10516537 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg b.i.d. orally for 14 days (CL group)
Number of subjects: 90
Study 10516537 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin plus cefuroxime 500 mg b.i.d. orally for 7 days (CLCE group)
Number of subjects: 90
Study 7488598 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% topical apraclonidine
Number of subjects: 100
Study 7488598 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% topical levobunolol
Number of subjects: 100
Study 7488598 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg oral acetazolamide
Number of subjects: 100
Study 7488598 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 7488598 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneoscleral tunnel technique
Number of subjects: 100
Study 7488598 — intervention group
Group type: COMPARATOR
Intervention: Corneoscleral suture technique
Number of subjects: 100
Study 7488598 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced surgeons
Number of subjects: 100
Study 7488598 — intervention group
Group type: COMPARATOR
Intervention: Inexperienced surgeons
Number of subjects: 100
Study 1974502 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (5 mg intravenously)
Number of subjects: 17
Study 1974502 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (6 mg intravenously)
Number of subjects: 17
Study 6118983 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudden cancellation of psychotropic drugs (with modifications such as combinations with sulfozine and diuretics)
Number of subjects: 64
Study 6118983 — intervention group
Group type: COMPARATOR
Intervention: Psychopharmacotherapy not interrupted (Control group)
Number of subjects: 64
Study 31999799 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight/obese group
Number of subjects: 153
Study 31999799 — intervention group
Group type: COMPARATOR
Intervention: Healthy weight group
Number of subjects: 153
Study 30947636 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth
Number of subjects: 163
Study 30947636 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth treatment responders
Number of subjects: 163
Study 30947636 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth nonresponders
Number of subjects: 163
Study 30947636 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based care
Number of subjects: 163
Study 29270003 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of telmisartan 40 mg and S-amlodipine 5 mg
Number of subjects: 0
Study 29270003 — intervention group
Group type: COMPARATOR
Intervention: Concomitant administration of telmisartan 40 mg and S-amlodipine 5 mg
Number of subjects: 0
Study 29270003 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (FDC and concomitant administration)
Number of subjects: 0
Study 26424421 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Number of subjects: 0
Study 26424421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23819227 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal cluster‐needling therapy
Number of subjects: 70
Study 23819227 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin
Number of subjects: 70
Study 21272382 — intervention group
Group type: EXPERIMENTAL
Intervention: Self management intervention
Number of subjects: 176
Study 21272382 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 176
Study 19341989 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga classes (twice weekly for 90 minutes over two months)
Number of subjects: 65
Study 19341989 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 65
Study 16881929 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-micronutrient Sprinkles with 12.5 mg iron as ferrous fumarate
Number of subjects: 133
Study 16881929 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-micronutrient Sprinkles with 20 mg iron as ferrous fumarate
Number of subjects: 133
Study 16881929 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-micronutrient Sprinkles with 30 mg iron as ferrous fumarate
Number of subjects: 133
Study 16881929 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-micronutrient Sprinkles with 20 mg iron as ferric pyrophosphate
Number of subjects: 133
Study 16881929 — intervention group
Group type: COMPARATOR
Intervention: Iron drops with 12.5 mg iron as liquid ferrous sulphate
Number of subjects: 133
Study 15450574 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (80 mg/m(2)) and docetaxel (60 mg/m(2)) chemotherapy prior to surgery (neoadjuvant group)
Number of subjects: 38
Study 15450574 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery without any previous chemotherapy)
Number of subjects: 38
Study 11264760 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 100 microg twice daily via Turbuhaler
Number of subjects: 350
Study 11264760 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg twice daily via Turbuhaler
Number of subjects: 350
Study 11264760 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 400 microg daily via pMDI
Number of subjects: 350
Study 11264760 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 800 microg daily via Turbuhaler
Number of subjects: 350
Study 11264760 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (both doses)
Number of subjects: 350
Study 9679718 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (5 microg x kg(‐1) x min(‐1))
Number of subjects: 26
Study 9679718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 8109545 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering diet
Number of subjects: 50
Study 8109545 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 2679681 — intervention group
Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin (1 g:2 g)
Number of subjects: 80
Study 2679681 — intervention group
Group type: COMPARATOR
Intervention: mezlocillin/oxacillin (2 g:1 g)
Number of subjects: 80
Study 1099501 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy consisting of DTIC with adriamycin, CCNU, or hydroxyurea.
Number of subjects: 110
Study 1099501 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with adriamycin and DTIC.
Number of subjects: 110
Study 1099501 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy consisting of DTIC with other agents (adriamycin, CCNU, hydroxyurea).
Number of subjects: 110
Study 1099501 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy consisting of DTIC with other agents.
Number of subjects: 110
Study 31092132 — intervention group
Group type: EXPERIMENTAL
Intervention: Full squat (F-SQ)
Number of subjects: 53
Study 31092132 — intervention group
Group type: EXPERIMENTAL
Intervention: Parallel squat (P-SQ)
Number of subjects: 53
Study 31092132 — intervention group
Group type: EXPERIMENTAL
Intervention: Half squat (H-SQ)
Number of subjects: 53
Study 31092132 — intervention group
Group type: COMPARATOR
Intervention: Control (training cessation)
Number of subjects: 53
Study 30839405 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (Ventolin) by nebulization (Group B; n = 20)
Number of subjects: 40
Study 30839405 — intervention group
Group type: COMPARATOR
Intervention: Regular insulin bolus with glucose infusion (Group A; n = 20)
Number of subjects: 40
Study 26786294 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal lifestyle intervention (dietary counselling twice by phone and access to twice‐weekly exercise groups during pregnancy)
Number of subjects: 606
Study 26786294 — intervention group
Group type: COMPARATOR
Intervention: Standard prenatal care (control group)
Number of subjects: 606
Study 26786294 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal lifestyle intervention (compliant participants)
Number of subjects: 606
Study 26786294 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal lifestyle intervention
Number of subjects: 606
Study 26786294 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 606
Study 26817181 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 184
Study 26817181 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 184
Study 23219570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) as an adjunct to usual care
Number of subjects: 469
Study 23219570 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 469